Chapter 11: Blood vessels Flashcards

1
Q

Three types of arteries

A
  • large elastic arteries (aorta)
  • medium muscular arteries (renal)
  • small arteries and arterioles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How are veins different from arteries?

A
  • larger diameters, larger lumens, thinner and less well organized walls
  • more susceptible to compression and penetration by tumors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define vasculogenesis, angiogenesis and arteriogenesis

A

Vasculogenesis: the formation of new vessels during embryologic development
Angiogenesis: new vessel formation in the mature organism
Arteriogenesis: remodelling of existing vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Response to vascular injury

A
  • stimulation of smooth muscle and extracellular matrix growth, creating a neointima
  • intimal thickening is the response to any vascular injury but also occurs in non-injured but aging vessels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Major causes of hypertension

A
  • idiopathic (>90% of cases)
  • renal (GN, renal artery stenosis, etc)
  • endocrine (Cusings, pheo, acromegaly, etc.)
  • cardiovascular (coarct, polyarteritis nodosa)
  • neurologic (increased ICP, sleep apnea)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Malignant hypertension

A
  • severe hypertension with associated retinal hemorrhage, renal failure, etc, can progressive to death in a 1-2 years
  • may arise de novo but often superimposed on pre-existing hypertension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Risk factors in hypertension

A
  • nonmodifiable: age, genetic makeup, gender, family history

- modifiable: hypercholesterolemia, hypertension, smoking, diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Steps in atherosclerosis

A
  • endothelial injury or dysfunction
  • accumulation of LDL in the vessel wall
  • monocyte adhesion with transformation of macrophages into foam cells in the plaque
  • platelet adhesion
  • smooth muscle cell recruitment via platelet derived factors
  • smooth muscle proliferation and ECM production
  • lipid accumulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the relationship of inflammation to the development of atherosclerosis?

A
  • normal endothelial cells don’t bind inflammatory cells, but dysfunctional ones express adhesion molecules for inflammatory cells
  • monocytes transform into macrophages that phagocytize lipid and recruit more inflammatory cells via cytokines and elaborate growth factors that promote smooth muscle proliferation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the role of smooth muscle proliferation in atherosclerosis?

A
  • smooth muscle converts the fatty streak into a mature atheroma
  • smooth muscle cells synthesis ECM components that stabilize the plaque
  • activated inflammatory cells cause smooth muscle cell apoptosis and thereby destabilize plaques
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the three main components of atherosclerotic plaques?

A
  • cells: smooth muscle cells, macrophages, T cells
  • extracellular matrix: collagen, elastic fibres, proteoglycans
  • intra and extracellular lipid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Complications of atherosclerotic plaques

A
  • plaque rupture, with exposure of the blood to thrombogenic substances in the plaque, resulting in thrombosis
  • hemorrhage into the plaque, which can result in rupture
  • atheroembolism
  • aneurysm resulting from weakening of the underlying elastic wall
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Define a critical stenosis of a vessel due to atherosclerosis

A
  • the degree of stenosis at which blood flow is significantly impeded with demand exceeding supply
  • approximately 70% occlusion
  • patients usually become symptomatic at this level
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are “vulnerable plaques”?

A

-those predisposed to rupture due to their composition, which may include thin fibrous caps, large components of foam cells and extracellular lipid or those with few smooth muscle cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Define pseudoaneurysm

A

-a defect in the vessel wall leading to an extravascular hematoma that communicates with the vessel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pathogenesis of aneurysms

A
  • intrinsically weak vessel walls (e.g. Marfan syndrome)
  • local inflammation or proteolytic enzymes make collagen degradation dominant over collagen synthesis (e.g. decreased levels of TIMP)
  • vessel weakening through loss of smooth muscle cells or deposition of inappropriate ECM components: cystic medial degeneration
17
Q

Clinical consequences of abdominal aortic aneurysms

A
  • rupture & hemorrhage
  • occlusion of structure such as ureter
  • embolism
  • occlusion of ostia of a branch vessel
  • presentation as an abdominal mass simulating a tumor
18
Q

Two groups of patients who develop aortic dissection

A
  • hypertensive men age 40-60

- young patients with localized or systemic abnormalities of collagen or other components of vessels

19
Q

Most common preexisting lesion in aortic dissection?

A

-cystic medial degeneration

20
Q

Immune complex vasculitis

A
  • SLE, polyarteritis nodosum
  • drug-induced vasculitis
  • viral infection-related vasculitis
21
Q

Possible mechanism for ANCA-associated vasculitis

A
  • ANCAs form in a susceptible host or as a result of induction by drugs or microbes
  • re-exposure or other stimulus cause surface expression of MPO or PR3 which react with ANCAs causing vascular injury
  • neutrophils degranulate and generate ROS which cause endothelial injury
22
Q

Polyarteritis nodosa

A
  • 30% of patients have chronic hep B, suggesting immune complex-mediated injury
  • segmental transmural necrotizing vasculitis of medium and small arteries
  • lungs less commonly affected
  • lesions are of varying ages
23
Q

Microscopic polyangiitis

A
  • lesions are all the same age at the same time

- necrotizing glomerulitis and pulmonary capillaritis are common

24
Q

Features of Churg-Strauss syndrome

A
  • peripheral eosinophilia, asthma, allergic rhinitis, lung infiltrates, small vessel necrotizing vasculitis and extravascular necrotizing granulomas
  • ANCAs present in <50%
  • myocardial infiltrates of eosinophils cause cytotoxicity and is the cause of death in some cases
25
Q

Features of WG

A
  • necrotizing granulomatous vasculitis of small to medium arteries
  • necrotizing granulomas of the upper respiratory tract
  • necrotizing crescentic glomerulonephritis
  • probably related to a T cell mediated hypersensitivity reaction to an inhaled antigen
26
Q

Thrombangiitis obliterans (Buerger disease)

A
  • segmental, thrombosing acute and chronic inflammation of medium and small arteries esp. tibial and radial arteries
  • smokers <35 years old (therefore probably related to smoking-induced endothelial toxicity)
  • thrombi typically contain microabscesses
27
Q

Primary vs. secondary Raynaud phenomenon

A

Primary: exaggeration of central and local vasomotor responses to cold and emotional stress; more often in young women; usually no significant vessel structural changes and usually benign course
Secondary: vascular insufficiency of the extremities due to other diseases such as SLE, scleroderma, etc

28
Q

Complications of angioplasty

A
  • immediate: embolism and abrupt reclosure due to thrombosis
  • later: proilferative restenosis: intimal thickening occurring in up to 50% of patients by 6 months; this can be seen with and without stents placed
29
Q

What is the long term patency of saphenous vein grafts?

A
  • 50% at 10 years
  • early occlusion due to thrombosis
  • months to years: intimal thickening, atherosclerosis, aneurysm (usually after years)
30
Q

How does HHV8 induce development of KS?

A

-disrupts cellular proliferation controls and prevents apoptosis by producing p53 inhibitors and a viral homologue of Cyclin D